A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors

NCT03995472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: SHR-1501
DRUG: SHR-1316

Sponsor

Jiangsu HengRui Medicine Co., Ltd.